Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.12 +0.05 (+2.42%)
As of: Oct 21, 2026 · 2:57 PM EDT

Black Diamond Therapeutics (BDTX) Interest Expenses (2020)

Updated

Black Diamond Therapeutics' Interest Expenses was $1,000 in FY2020.

Analysis

Black Diamond Therapeutics (BDTX) Interest Expenses (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,137.36 Bn 1,105.95 Bn 19.71 Bn -
2 Johnson & Johnson 617.62 Bn 536.15 Bn 17.26 Bn 281.00 Mn
3 AbbVie 501.17 Bn 474.28 Bn 12.70 Bn -
4 Merck 368.13 Bn 322.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 261.23 Bn 234.92 Bn 12.86 Bn 435.00 Mn
7 Amgen 236.68 Bn 192.08 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 190.97 Bn 165.17 Bn 6.22 Bn 247.00 Mn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn -
10 Black Diamond Therapeutics 122.19 Mn -370.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 1,000.00
API Access

Black Diamond Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=BDTX&period=max&api_key=YOUR_API_KEY